Drug Profile
Hepatitis B vaccine - Bavarian Nordic
Alternative Names: HBV vaccine - Bavarian Nordic; Modified Vaccinia Ankara Bavarian Nordic HBV vaccine; MVA-BN HBV vaccine; MVA-BN Hepatitis B vaccine - Bavarian NordicLatest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator Bavarian Nordic
- Developer Janssen
- Class Hepatitis B vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 24 Nov 2021 Discontinued - Preclinical for Hepatitis B in USA (Parenteral) (Bavarian Nordic pipeline, November 2021)
- 28 Oct 2021 No recent reports of development identified for preclinical development in Hepatitis-B in USA (Parenteral)
- 29 Sep 2017 Preclinical trials in Hepatitis B in USA (Parenteral) before September 2017 (Bavarian Nordic pipeline, September 2017)